OCRELIZUMAB
ocrelizumab 920 mg/23 mL injection, 23 mL vial
OCRELIZUMAB (15120T)
15120T
Manner of administration:Injection
Restriction (Streamlined authority code: 7699)
Indication: Multiple sclerosis
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 7386)
Indication: Multiple sclerosis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $16,656.36 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ocrevus SC | |||||